SCHEMBL10143413

SCHEMBL10143413

COc1ccc(Nc2cc(N3CCN(c4ccccc4)CC3)nc(N3CCCC3)n2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GALR2 O43603 15/20 1.00
GALR1 P47211 7/20 1.00
MAPK1 P28482 3/20 0.55
TAAR1 Q96RJ0 1/20 0.55
MAPT P10636 4/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
KDM4E B2RXH2 1/20 0.55
APAF1 O14727 1/20 0.55
NSD2 O96028 1/20 0.55
GAA P10253 1/20 0.55
HTT P42858 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55
SAE1 Q9UBE0 1/20 0.55
UBA2 Q9UBT2 1/20 0.55
TDP1 Q9NUW8 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10144339 0.90 GALR2 (0.82) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL3240927 0.87 GALR2 (0.77) GALR2GALR1MAPTAPAF1GAA
SCHEMBL10143796 0.85 GALR2 (1.00) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL10144392 0.83 GALR2 (1.00) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL10143418 0.83 GALR2 (0.86) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL23221587 0.80 GALR2 (0.66) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL3240515 0.79 GALR2 (0.64) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL10144388 0.78 GALR2 (1.00) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL18162430 0.78 GALR2 (0.64) GALR2GALR1MAPK1TAAR1MAPT
SCHEMBL10144177 0.78 GALR2 (0.82) GALR2GALR1MAPK1TAAR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009258-A2 PEPTIDOMIMETIC GALANIN RECEPTOR MODULATORS ROBERTS EDWARD (US) 2012-01-19 WO disclosed